文献速递临床生化临床免疫质量管理与危急值

新兴滥用药物及其检测方法:ACLPS批判性综述

Newly Emerging Drugs of Abuse and Their Detection Methods: An ACLPS Critical Review.
PubMed 文献 · Am J Clin Pathol · 2018-01-01

美国非法药物滥用已达流行水平,2008年以来药物过量成为伤害相关死亡首因,海洛因、管制处方药和非美沙酮合成阿片类过量激增。合成卡西酮和合成大麻素等新型设计药物持续涌现,给临床毒理学实验室带来挑战。综述指出非靶向质谱筛查是有前景的方法,LC-MS/MS和LC-HRMS简化样品制备并提高新药检测能力,成为新标准。

要点

  • 美国药物过量死亡主要由海洛因、管制处方药和非美沙酮合成阿片类驱动。
  • 合成卡西酮和合成大麻素等新型设计药物持续涌现且缺乏FDA批准的筛查方法。
  • LC-MS/MS和LC-HRMS简化样品制备并提高新药检测能力,成为新标准。

核心结论

  • LC-MS/MS和LC-HRMS简化样品制备并提高新药检测能力,成为新的标准。

研究设计与样本

  • 本文为ACLPS批判性综述,回顾可用于识别新兴滥用药物检测的方法。

主要发现

  • 美国非法药物滥用已达流行水平,2008年以来药物过量成为伤害相关死亡首因。
  • 海洛因、管制处方药和非美沙酮合成阿片类过量激增。
  • 合成卡西酮和合成大麻素等新型设计药物持续涌现并吸引休闲使用者。
  • 新兴药物及其代谢信息有限、非法药物换名重新包装以及缺乏FDA批准的筛查方法共同构成困难。

关键数值与推荐

  • 非靶向质谱筛查是应对新兴滥用药物的有前景方法。
  • 气相色谱-质谱联用历史上是金标准。
  • LC-MS/MS和LC-HRMS简化样品制备并提高新药检测能力,成为新标准。

临床怎么用

  • 临床毒理学实验室可采用非靶向质谱筛查辅助识别新兴滥用药物。
  • LC-MS/MS和LC-HRMS因简化样品制备和提升新药检测能力可作为新标准方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Illicit drug abuse has reached an epidemic level in the United States. Drug overdose has become the leading cause of injury-related deaths since 2008 due to the recent surge of opioid overdose by heroin, controlled prescription drugs, and nonmethadone synthetic opioids. Synthetic designer drugs such as synthetic cathinones ("bath salts") and synthetic cannabinoids ("Spice" and "K2") continue to emerge and attract recreational users. METHODS: The emergence of new drugs of abuse poses a steep challenge for clinical toxicology laboratories. Limited information about the emerging drugs and their metabolism, "rebranding" of the illicit drugs, and a lack of Food and Drug Administration-approved screening methods for these drugs contribute to this difficulty. Here we review detection methods that can aid in identifying emerging drugs of abuse. RESULTS: One promising approach is the utilization of untargeted drug screening by mass spectrometry. Historically, gas chromatography-mass spectrometry has been the gold standard. CONCLUSIONS: Liquid chromatography-tandem mass spectrometry and liquid chromatography-high-resolution mass spectrometry offer improved detection capability of new drugs with simplified sample preparation, making it the new standard.

来源:Am J Clin Pathol,查看原文。版权归原作者所有。

引用

  1. Liu L, Wheeler SE, Venkataramanan R, et al. Newly Emerging Drugs of Abuse and Their Detection Methods: An ACLPS Critical Review. Am J Clin Pathol. 2018. PMID: 29385414. doi:10.1093/ajcp/aqx138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。